Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Clinterooon Mar 21, 2011 7:27pm
376 Views
Post# 18318748

RE: Some calculations

RE: Some calculationsWhat calculations are you talking about?

I just hope nobody is stupid enough to believe what they read.

Who cares what the market cap of the other companies are???? You are essentially saying "the average market cap of the 8 companies that used Bloom is $100 million, therefore, the market cap of SSS will be $100 million".

Why doesn't the company use the same marketing firm as Microsoft or Coca-Cola. Then you could say....

"Hey guys, the average market cap of companies that used XYZ Marketing was $100 billion. SSS is now using XYZ Marketing, therefore, our market cap is going to $100 Billion... or $600 per share"

Good God.
Bullboard Posts